A group of global, regional, and national palliative care organisations has urged governments and regulators to take steps to end the practice of pharmaceutical companies marketing sustained-release morphine and expensive opioid formulations, and to ensure the availability of generic immediate-release oral morphine for pain management.
[News] Morphine manifesto seeks to boost access to oral morphine
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
LATEST
Sign up for our emails
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Newsletter
Privacy Policy